Chitosan Membranes Stabilized with Varying Acyl Lengths Release Cis-2-Decenoic Acid and Bupivacaine at Controlled Rates and Inhibit Pathogenic Biofilm

Landon Reed Choi,Zoe Harrison,Emily C Montgomery,Joshua R Bush,Ezzuddin Abuhussein,Joel D Bumgardner,Tomoko Fujiwara,Jessica Amber Jennings,Emily C. Montgomery,Joshua R. Bush,Joel D. Bumgardner
DOI: https://doi.org/10.31083/j.fbl2903108
IF: 3.1
2024-03-18
Frontiers in Bioscience-Landmark
Abstract:BACKGROUND: Adherence of complex bacterial biofilm communities to burned tissue creates a challenge for treatment, with infection causing 51% of burn victim deaths. This study evaluated the release of therapeutics from wound care biomaterials and their antimicrobial activity against pathogens <i>Staphylococcus aureus</i>, <i>Acinetobacter baumannii</i>, and <i>Pseudomonas aeruginosa</i>.METHODS: Electrospun chitosan membranes (ESCMs) were fabricated and acylated with chain lengths ranging from 6-10 carbons then loaded with 0.15 mg of anti-biofilm agent, cis-2-decenoic acid (C2DA), and 0.5 mg of local anesthetic, bupivacaine.RESULTS: Combinations of therapeutics released from modified ESCMs at a cumulative amount of 45-70% of bupivacaine and less than 20% of C2DA. Results from bacterial studies suggest that this combination reduced biofilm 10-fold for <i>S. aureus</i>, 2-fold for <i>Acinetobacter baumannii</i>, and 2-3-fold for <i>Pseudomonas aeruginosa</i> by 24 hours. Additionally, dual loaded groups reduced planktonic <i>Staphylococcus aureus</i> ~4-fold by 24 hours as well as <i>Acinetobacter baumannii</i> ~3-fold by 48 hours.CONCLUSIONS: The combination of therapeutics used has a significant role in biofilm prevention for selected strains via direct contact or diffusion in aqueous solutions.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?